会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 42. 发明公开
    • PHARMACEUTICAL COMPOSITION FOR THE CONTROLLED RELEASE OF METHYLPHENIDATE
    • 药剂师ZUSAMMENSETZUNGFÜRDIE GESTEUERTE FREISETZUNG VON METHYLPHENIDAT
    • EP2368546A2
    • 2011-09-28
    • EP09824989.9
    • 2009-11-06
    • Samyang Corporation
    • PARK, Sang YeobCHUNG, HojinPAI, Chaul Min
    • A61K9/28A61K31/445A61K9/16A61K9/26A61K9/32A61K9/50A61K47/00
    • A61K9/0095A61K9/0056A61K9/5073A61K31/445
    • Disclosed is a pharmaceutical composition for controlled release, comprising a core material containing methylphenidate, and a plurality of particles for controlled release, containing a polymer coating layer for controlled release, formed on the core material. The plurality of particles for controlled release is divided into two or more groups based on the average thickness of the polymer coating layer for controlled release. The particle groups are identical in terms of the composition of the polymer in the polymer coating layer, but are different in terms of the average thickness of the coated layer. The pharmaceutical composition for controlled release according to the present invention may control the release pattern of methylphenidate contained in the core material as desired, and can be used as an oral formulation in a variety of forms such as quick dissolving tablets, etc.
    • 公开了一种用于控释的药物组合物,其包含含有哌甲酯的核心材料和多个用于控制释放的颗粒,其包含形成在芯材上的用于控制释放的聚合物涂层。 基于用于控制释放的聚合物涂层的平均厚度,将多个用于控释的颗粒分成两组或更多组。 在聚合物涂层中聚合物的组成方面,颗粒组是相同的,但是在涂层的平均厚度方面是不同的。 根据本发明的用于控制释放的药物组合物可以根据需要控制芯材中包含的哌甲酯的释放模式,并且可以以各种形式如快速溶解片剂等的口服制剂使用。